Myhealthchecked Share Discussion Threads

[dual] 04/4/2024 13:02

Good to see these test selling.The bad news is Boots has teamed up with Abingdon Health to supply its own brand of LFT.https://www.abingdonhealth.com/news/boots-to-sell-own-brand-self-tests-via-abingdon-health-crest-medical-partnership/

[tia01] 04/4/2024 11:40

You’d think us long term holders need to be given heart profile tests free given the effect this share has. Lol

[tia01] 04/4/2024 11:20

hxxps://www.boots.com/myhealthchecked-cholesterol-profile-bloodtest-10322833

Even cholesterol tests selling!
Ain’t seen this before!
Maybe there is some traction on the way and hopefully for all us long term sufferers a little slack

[control1] 04/4/2024 08:33

Looks like results have leaked then...

[tia01] 03/4/2024 23:10

Today for me was exactly what I assumed may happen. We fell to 11.25p which is a one year support level. It hit it 3 times and so I’m hoping we can put a base in and rise. One year ago today we announced results however how ironic we should fall to 1 year support line of 11.25p.
News on new products is the key as COVID income slows. I just ask how a board has failed to capitalise on weakness in other stocks and not considered a takeover bargan as companies struggle. So strange they remain silent and date on results. I just feel many investors have deserted think due to lack action from the Directors etc. They really need to question whether they have done anything with the money raised from COVID revenue or just going to continue taking decent salaries at investors expense. Sorry but the share price and less than 6m valuation demonstrates the lack of action from the board who really need to take a look at themselves and justify salaries

[tia01] 03/4/2024 13:02

When it’s down it’s down.
News needed 100%
Down on low volume!
Last few big transactions could were very strange.
Management haven’t soon anything to increase shareholder value.
Actually they’ve killed it

[tia01] 28/3/2024 07:49

I guess when you look at companies like GDR with results today showing they have great products but miss managed cash you have to be grateful for out board with Penny leading it. Extremely prudent and self sufficient.
With a Market cap of just 4.5m and no cash could GDR be a good takeover to strip the assets and cement a presence!
Someone will be considering it a cheap takeover in my opinion minus the management

[tia01] 27/3/2024 17:29

Control
I suspect many have given up.
The boards lack of updates and buying themselves sends the wrong signals

[control1] 27/3/2024 12:16

I haven't given up, I have many and do expect to make a ROI here...MHC could start by returning some of the war chest to shareholders in the form of a divi, as previously eluded to.

[tia01] 26/3/2024 22:36

With the 25pk of covid being re stocked and selling well immediately it’s clear that the government pulling tests for care home elderly people that care homes will need to buy them privately. Finally MHC have realised but it’s took months to restock the 25pk. Let hope demand ensures they need to keep restocking it

[tia01] 26/3/2024 17:52

Billy
April 3rd last year.
Expect a natural slowdown since February in Covid tests but I also expect modest pick up in new test sold in store.

I would be more interested if MHC can embark on sales agreements in more stores before ABDX beat them at it.
Time to grow without relying on Boots as they clearly intend to have there own brands in lines that are gaining traction and given they are selling them they have the crucial data.

Interesting to see if plans with digital data makes any difference

[billy3] 25/3/2024 19:34

No results yet and we are almost in April !!!!

[tia01] 25/3/2024 18:38

hxxps://news.sky.com/story/amp/routine-covid-tests-for-hospital-patients-discharged-into-care-homes-to-be-ended-by-government-13101636

I’m surprised MHC don’t supply direct to major care homes. They will need private tests still in my opinion

[tia01] 24/3/2024 18:19

Was in Birmingham today shopping and popped into Boots. Found the MHC brand on a top shelf near the chemist counter.
I asked the woman who was stocking the items how sales were going. She seemed a bit confused by my question but proceeded to say she’s regularly restocking the shelves every week. I guess my point is the reall sales momentum could be attributed to the instore sales in my opinion. Strangely the only select various lines though.

[tia01] 22/3/2024 13:44

Most people have all but given up seeing any return here. Sad given it’s balance sheet but that’s the unfortunate reality as most been burnt to bad

[tia01] 22/3/2024 13:29

Blackhorse
That graph no better than this one and a market cap of 210m.
I’d say most investors would be equally as pi—ed as this one.

[blackhorse23] 22/3/2024 11:27

Money moving to APH [LSE] , excellent profitable healthcare company

[tia01] 22/3/2024 10:59

Weatherman
We won’t know until results.
Last year they were 3rd April.
When do we think this year.
I’m expecting a slowdown in covid sales however a good month in January but real growth in probably half the new tests. The more expensive ones other the tolerance test will gain traction if a deal is done with the government and chemists to allow patients to buy them on prescription using the chemists as a port of call. Similar to the last 7 tests gone that way. It will be huge save to the government and cut GP waiting time. I think this is why MHC is pumping so much into digital data.
Penny needs to be more transparent

[weatherman] 22/3/2024 09:08

Sells through Boots - seems more successful than MHC, perhaps through better marketing.

[tia01] 20/3/2024 08:54

Surely Penny must have a plan to expand and not just Boots.

[tia01] 20/3/2024 08:35

I thought that also.
MHC need to seek alternative arrangements with independent stores etc.
Boots will wish to promote own brand surely!

[muck165] 20/3/2024 07:18

I see ABDX are now assisting Boots with own brand tests. I did wonder if they might get some entry into Boots but tbh thought that would be through collaboration with MHC.

[tia01] 20/3/2024 07:00

A collaboration would be good but as said MHC have cash and need to create more revenue from growth in product sales.

ABDX have great products and revenue growing but cash burn is the problem.

Both have potential

[muck165] 19/3/2024 09:42

Hi Tia - imo both are great businesses and both are undervalued, but I don't think they're comparable. Yes, MHC has more cash but it is, as far as I can see, centred entirely on human health and wellbeing, and still reliant heavily on Covid related income. ABDX currently has 29 projects in its hopper, covering a diverse mix of LFT applications across human, plant, environmental, animal testing, with Salistick merely being the first to commercialise but others shortly to do so. These include two tests selected by the govt to be part of its new IDAP scheme (8 in total), intended to fast track the most transformative tests into widespread use in the NHS. SO it is not just targeting retail and its potential revenue streams are diverse and certainly not weighted to Covid. MHC may well be in the better balance sheet position right now, but for me the greater potential lies with ABDX and, perhaps, both could benefit by enhancing the collaboration which has existed between the two companies since 2020.